Jesse Keller

Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score

Kristen M. Sanfilippo, Suhong Luo, Tzu‐Fei Wang et al. · American Journal of Hematology · 2019 · 175 citations · Full text

Medicine, Oncology, Pharmacology +17

Severe Cytokine-Release Syndrome after T Cell–Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti–IL-6 Therapy Is Safe and Well Tolerated

Ramzi Abboud, Jesse Keller, Michael Slade et al. · Biology of Blood and Marrow Transplantation · 2016 · 166 citations · Full text

Medicine, Hematology, Immunology +14

Statins Are Associated With Reduced Mortality in Multiple Myeloma

Kristen M. Sanfilippo, Jesse Keller, Brian F. Gage et al. · Journal of Clinical Oncology · 2016 · 92 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents

Sahaja Acharya, Mustafaa Mahmood, D. Mullen et al. · Advances in Radiation Oncology · 2017 · 73 citations · Full text

Medicine, Oncology, Radiation Oncology +16

The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.

Steve Devine, RB Geller, Liming Lin et al. · PubMed · 1997 · 35 citations

Pharmacy, Hematology, Immunology +14